Rabies cost-effectiveness of therapy

Jump to: navigation, search

Rabies Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Rabies from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Rabies cost-effectiveness of therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Rabies cost-effectiveness of therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Rabies cost-effectiveness of therapy

CDC on Rabies cost-effectiveness of therapy

Rabies cost-effectiveness of therapy in the news

Blogs on Rabies cost-effectiveness of therapy

Directions to Hospitals Treating Rabies

Risk calculators and risk factors for Rabies cost-effectiveness of therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Although human rabies deaths are rare, the estimated public health costs associated with disease detection, prevention, and control have risen, exceeding $300 million annually. These costs include the vaccination of companion animals, animal control programs, maintenance of rabies laboratories, and medical costs, such as those incurred for rabies postexposure prophylaxis (PEP).

Cost-Effectiveness of Therapy

Accurate estimates of these expenditures are not available. Although the number of PEPs given in the United States each year is unknown, it is estimated to be about 40,000. When rabies becomes epizootic or enzootic in a region, the number of PEPs in that area increases. Although the cost varies, a course of rabies immune globulin and five doses of vaccine given over a 4-week period typically exceeds $1,000 in industrialized nations. In developing countries, the cost is approximately $100-$300[1]. The cost per human life saved from rabies ranges from approximately $10,000 to $100 million, depending on the nature of the exposure and the probability of rabies in a region.

Milwaukee Protocol

The famous case of Jeanna Giese required a drastic and experimental protocol. This therapy has been attempted on subsequent patients since her diagnosis in 2004, but the major problem is the total expense of it. Dr. Rodney Willoughby, the doctor who treated Giese, estimated that the total cost of her treatment, using the Milwaukee protocol, was approximately $800,000[1].

References

  1. 1.0 1.1 "Medical Mystery: Only One Person Has Survived Rabies without Vaccine--But How?: Scientific American". Retrieved 2012-02-10.

Linked-in.jpg